The pilot year of ExPAND Mifepristone included two FQHCs who successfully implemented mifepristone for EPL and devised new abortion referral protocols. The following cohort (2022-2023) included three additional clinics, two of which are now offering mifepristone for EPL and abortion care. Future directions include continuing to expand the evidence-based provision of reproductive health services in primary care and analyzing the effectiveness of the learning collaborative in terms of improved patient-centeredness and clinical outcomes.
As ExPAND Mifepristone continues to grow, we hope to cultivate a longstanding network of PCPs and clinical sites equipped with the resources and training needed to expand and protect access to essential reproductive healthcare.
Participation Opportunities
ExPAND Learning Collaborative (12 months) – Cohort 3 launched November 2023
- One-year virtual learning collaborative
- Participating clinics receive expert clinical, policy/regulatory, and technical assistance with individualized support throughout the program, according to a customized workplan
- Clinics participate in evaluation activities, including pre-course assessment and staff engagement in pre- and post- surveys and interviews
- Small grants to each site defray start-up costs and protect participants’ time to participate
ExPAND Condensed Course (4 months) –applications released late January 2024
- Four-month program with monthly synchronous virtual sessions
- Participants complete asynchronous pre-work before each session and participate in evaluation activities, including pre-course assessment and staff engagement in pre- and post- surveys
If your clinic is interested in learning more about ExPAND Mifepristone or discussing possible participation in the next cohort, please contact Artria Irving at Artria.Johnson@bsd.uchicago.edu.